Neurology Advisor Contributing Writer

In a case-control study, researchers evaluated the association between disease-modifying antirheumatic drugs and the risk of developing Parkinson disease in patients with rheumatoid arthritis.

Researchers sought to identify the trajectories of insomnia in the 12 months following incidence of traumatic brain injury.

In a small study, researchers identified the clinical characteristics of patients who develop cognitive PASC after mild SARS-CoV-2 infection and inform pathogenesis.

In a retrospective, observational study, researchers determined the impact of COVID-19 infection in patients with myasthenia gravis.

Researchers sought to examine the presence of CML and NOX2 proinflammatory factors in the brain microvasculature of patients with myocardial infarction.

Researchers sought to determine whether screening vs no screening for atrial fibrillation could reduce morbidity and mortality.

Using data on patients with existing atrial fibrillation (AF), researchers analyzed the link between diabetes with the AF phenotype and cardiac and neurologic comorbidities.

Researchers studied whether moderate vs mild therapeutic hypothermia could improve clinical outcomes in comatose survivors of out-of-hospital cardiac arrest.

Investigators participating in the TeleSCOPE study deployed a survey to evaluate the management of drug-induced movement disorders via telehealth during the COVID-19 pandemic.

A high prevalence of depression and anxiety symptoms was found among patients with diabetic polyneuropathy.

A team of investigators sought to assess the impact of patients’ symptoms of tardive dyskinesia on the individuals caring for them.

Investigators used data from the Enroll-HD registry to assess patterns of treatment for chorea in patients with Huntington disease.

Researchers investigated the effect of alpha-lipoic acid (ALA) on oxidative, inflammatory, and mood conditions in women with episodic migraine.

Researchers shared their findings on the relationship between metabolic factors, like blood markers of lipid and carbohydrate metabolism, and the risk of developing amyotrophic lateral sclerosis.

Researchers assessed the safety and efficacy of nonimmunogenic recombinant staphylokinase compared with alteplase in patients with acute ischemic stroke within 4.5 hours following symptom onset.

Authors performed a systematic review of current evidence for the use of the Atrial Fibrillation Better Care (ABC) pathway and its effect on clinical outcomes.

A young man is diagnosed with cauda equina syndrome on his third visit to an emergency department. Early and late CES signs/symptoms are discussed in this case study

The association between stroke and obesity in adolescence was examined in a population-based study.

Compared to teriflunomide, ponesimod showed benefit for magnetic resonance imaging (MRI) outcomes in relapsing multiple sclerosis.

ADS-5102, the extended release capsule form of amantadine, may clinically benefit walking speed in patients with multiple sclerosis.

In secondary progressive multiple sclerosis, amiloride, fluoxetine, and rizuole treatments do not translate into long-term reduction in atrophy rates.

Baseline levels of ubiquitin C-terminal hydrolase L1 in cerebral spinal fluid may be predictive of long term multiple sclerosis progression.

The terminal complement inhibitor eculizumab reduced the risk of relapse in patients with neuromyelitis optica spectrum disorder (NMOSD).

Ozanimod may be a safe and well-tolerated treatment for relapsing forms of multiple sclerosis.

Individuals with relapsing-remitting MS who respond suboptimally to DMT may experience improvement with the addition of an SSRI.

Researchers analyzed whether hypertension onset occurs at an earlier age in individuals with multiple sclerosis who were born post-1965.

The Wahls elimination diet had more significant effects on quality of life for individuals with relapsing-remitting multiple sclerosis as compared to the Swank diet.

Effectiveness of disease modifying therapies for multiple sclerosis was shown to be associated with shorter disease duration and lower relapse rate.

Investigators posit that wearable devices will help psychiatrists to target mood and cognitive interventions.

Researchers compared the health-related quality of life in patients with Sjögren syndrome, with and without peripheral neuropathy.